Hint mode is switched on Switch off

CG Oncology, ordinary share
CGON, US1569441009

Add a stock to WL
Choose all Reset all
CG Oncology, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer.
  • Issuer
  • Full borrower / issuer name
    CG Oncology Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CGON
  • Placement
    25.01.2024
  • Lock up period
    180
  • Number of papers
    20,000,000
  • Volume of raised funds
    380 mln USD
  • Placement share
    31.5%
  • Final placement price
    19 USD
  • Price change since placement date
    191.89%
  • By capitalization
    1,206.17 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CGON
  • Placement
    13.12.2024
  • Lock up period
    180
  • Number of papers
    8,000,000
  • Volume of raised funds
    224 mln USD
  • Placement share
    10.69%
  • Final placement price
    28 USD
  • Price change since placement date
    98.07%
  • By capitalization
    2,095.46 mln USD

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

13/04/2026 CG Oncology: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
13/01/2026 CG Oncology: Other Events, Financial Statements And Exhibits
09/09/2025 CG Oncology: Regulation Fd Disclosure, Financial Statements And Exhibits
07/07/2025 CG Oncology: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
05/06/2025 CG Oncology: Submission Of Matters To A Vote Of Security Holders
All organization news

Holders

Industry Leaders

Registration is required to get access.